GELASPAN

This brand name is authorized in Ecuador, Estonia, Spain, France, Ireland, Lithuania, Malta, Netherlands, Poland, Romania, Singapore, United Kingdom

Active ingredients

The drug GELASPAN contains a combination of these active pharmaceutical ingredients (APIs):

1 Succinylated gelatin
UNII 2G86QN327L - GELATIN, UNSPECIFIED

Gelatin is a colloidal plasma substitute. When used in the treatment of hypovolaemia gelatin produces significant increases in blood volume, cardiac output, stroke volume, blood pressure, urinary output and oxygen delivery. Gelatin promotes osmotic diuresis, thereby helping to protect the kidneys from the adverse effects of hypovolaemia.

Read about Gelatin
2 Sodium chloride
UNII 451W47IQ8X - SODIUM CHLORIDE

Sodium chloride is the principle salt involved in maintaining the osmotic tension of blood and tissues. Changes in osmotic tension influence the movement of fluids and diffusion of salts in cellular tissue.

Read about Sodium chloride
3 Sodium acetate trihydrate
UNII 4550K0SC9B - SODIUM ACETATE
Read about Sodium acetate
4 Potassium chloride
UNII 660YQ98I10 - POTASSIUM CHLORIDE

Potassium plays a vital physiological role in maintenance of normal electrical excitability of nerve and muscle. It is also important in the genesis and correction of imbalances of acid-base metabolism.

Read about Potassium chloride
5 Calcium chloride dihydrate
UNII M4I0D6VV5M - CALCIUM CHLORIDE

Calcium is the most abundant mineral in the body, and is an essential body electrolyte. Homeostasis is mainly regulated by the parathyroid hormone, by calcitonin, and by the activated form of vitamin D. Calcium is a structural component of bones and teeth. It is also required for blood clotting, neurotransmitter release, muscle contraction and normal heartbeat.

Read about Calcium chloride
6 Magnesium chloride hexahydrate
UNII 02F3473H9O - MAGNESIUM CHLORIDE
Read about Magnesium chloride

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
B05AA06 Gelatin agents B Blood and blood forming organs → B05 Blood substitutes and perfusion solutions → B05A Blood and related products → B05AA Blood substitutes and plasma protein fractions
Discover more medicines within B05AA06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: EC Agencia Nacional de Regulación, Control y Vigilancia Sanitaria Identifier(s): 974-MEE-0515
Country: EE Ravimiamet Identifier(s): 1722158, 1722169
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 76222
Country: FR Base de données publique des médicaments Identifier(s): 69083660
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 212914, 239837
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1053843, 1053844
Country: MT Medicines Authority Identifier(s): MA223/01501
Country: NL Z-Index G-Standaard, PRK Identifier(s): 38040
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100254217
Country: RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale Identifier(s): W57829001, W57829002
Country: SG Health Sciences Authority Identifier(s): 15336P

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.